Etiology, laboratory testing and laboratory biological safety protection of SARS-CoV-2

doi:10.3969/j.issn.1673-8640.2020.03.019

Laboratory Medicine ›› 2020, Vol. 35 ›› Issue (3): 278-281.DOI: 10.3969/j.issn.1673-8640.2020.03.019

Previous Articles Next Articles

Etiology, laboratory testing and laboratory biological safety protection of SARS-CoV-2

Lai Yuanyuan¹, Wang Yuting¹, Chen Jiani¹, Qi Jun¹(), He Zhenye²

1.National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, 518116, China
2.Department of Gynecology, Union Shenzhen Hospital, Huazhong University of Science and Technology, Shenzhen,518000, China

Received:2020-02-27 Online:2020-03-30 Published:2020-04-17
Contact: Qi Jun

Abstract

Abstract:

On December, 2019, an outbreak of pneumonia caused by a novel coronavirus that was first detected in Wuhan City, Hubei Province, China and which has now been detected in other regions in China and abroad. The virus seems to be highly contagious and has a high fatality rate. The rapid and accurate laboratory test is very important for the diagnosis and treatment of the novel coronavirus pneumonia and the clinical specimenscollected from patients with COVID-19 for testing have potential pathogenicity and high infectivity. Therefore, the laboratory test of SARS-CoV-2 and the management of clinical laboratory have become the research topics in China.The related measures of prevention and control are summarized.

Key words: Novel coronavirus, Etiological features, Clinical laboratory testing, Bio-safety protec

CLC Number:

R446.1

Lai Yuanyuan, Wang Yuting, Chen Jiani, Qi Jun, He Zhenye. Etiology, laboratory testing and laboratory biological safety protection of SARS-CoV-2[J]. Laboratory Medicine, 2020, 35(3): 278-281.

References 21

[1]	WANG D,HU B,HU C,et al.Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan,China[J]. JAMA,2020.[Online ahead of print]
[2]	ZHU N,ZHANG D,WANG W,et al.A novel coronavirus from patients with pneumonia in China,2019[J]. N Engl J Med,2020,382(8):727-733.
[3]	WU A,PENG Y,HUANG B,et al.Genome composition and divergence of the novel coronavirus(2019-nCoV) originating in China[J]. Cell Host Microbe,2020,27(3):325-328.
[4]	WRAPP D,WANG N,CORBETT K S,et al.Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation[J]. Science,2020,367(6483):1260-1263.
[5]	国家卫生健康委办公厅,国家中医药管理局办公室. 新型冠状病毒肺炎诊疗方案(试行第七版)[EB/OL]. (2020-03-03)[2020-03-04]. .
[6]	2019新型冠状病毒肺炎临床实验室生物安全防护专家共识,2020.2.5.
[7]	WANG C,HORNBY P W,HAYDEN F G,et al.A novel coronavirus outbreak of global health concern[J]. Lancet,2020,395(10233):470-473.
[8]	HUANG C,WANG Y,LI X,et al.Clinical features of patients infected with 2019 novel coronavirus in Wuhan,China[J]. Lancet,2020,395(10223):497-506.
[9]	LIU J,LIU Y,XIANG P,et al.Neutrophil-to-lymphocyte ratio predicts severe illness patients with 2019 novel coronavirus in the early stage[J]. medRvix,2020.[Online ahead of print]
[10]	XU Z,SHI L,WANG Y,et al.Pathological findings of COVID-19 associated with acute respiratory distress syndrome[J]. Lancet Respir Med,2020.[Online ahead of print]
[11]	刘映霞,杨扬,张聪,等. 新型冠状病毒(2019-nCoV)感染患者肺损伤相关的临床及生化指标研究[J].中国科学:生命科学,2020. [网络优先出版]
[12]	LI Z,WU M,GOU J,et al.Caution on kidney dysfunctions of 2019-nCoV patients[J]. medRvix,2020.[Online ahead of print]
[13]	TANG N,LI D,WANG X,et al.Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia[J]. J Thromb Haemost,2020.[Online ahead of print]
[14]	ZHANG N,WANG L,DENG X,et al.Recent advances in the detection of respiratory virus infection in humans[J]. J Med Virol,2020,92(4):408-417.
[15]	WANG M,FU A,HU B,et al.Nanopore target sequencing for accurate and comprehensive detection of SARS-CoV-2 and other respiratory viruses[J]. medRvix,2020.[Online ahead of print]
[16]	国家卫生健康委办公厅. 医疗机构内新型冠状病毒感染预防与控制技术指南(第一版)[EB/OL]. (2020-01-22)[2020-02-27]. .
[17]	国家卫生健康委办公厅. 新型冠状病毒实验室生物安全指南(第二版)[EB/OL]. (2020-01-23)[2020-02-05]. .
[18]	中华医学会检验分会. 2019新型冠状病毒肺炎临床实验室检测的生物安全防护指南(试行第一版)[EB/OL]. (2020-01-30)[2020-02-05]. .
[19]	国家卫生健康委办公厅. 新型冠状病毒肺炎防控方案(第五版)[EB/OL]. (2020-02-21)[2020-02-05]. .
[20]	WS/T 367—2012消毒技术规范[S]. 2012.
[21]	国家卫生健康委办公厅. 国家卫生健康委办公厅关于做好新型冠状病毒感染的肺炎疫情期间医疗机构医疗废物管理工作的通知[EB/OL]. (2020-01-28)[2020-02-27]. .

Etiology, laboratory testing and laboratory biological safety protection of SARS-CoV-2

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 21

Related Articles 1

Recommended Articles

Metrics